Global Biological API Drug Manufacturing Supply, Demand and Key Producers, 2023-2029

Global Biological API Drug Manufacturing Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 14 Mar 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.

This report studies the global Biological API Drug Manufacturing production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biological API Drug Manufacturing, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological API Drug Manufacturing that contribute to its increasing demand across many markets.

The global Biological API Drug Manufacturing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Biological API Drug Manufacturing total production and demand, 2018-2029, (K MT)
Global Biological API Drug Manufacturing total production value, 2018-2029, (USD Million)
Global Biological API Drug Manufacturing production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Biological API Drug Manufacturing consumption by region & country, CAGR, 2018-2029 & (K MT)
U.S. VS China: Biological API Drug Manufacturing domestic production, consumption, key domestic manufacturers and share
Global Biological API Drug Manufacturing production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K MT)
Global Biological API Drug Manufacturing production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Biological API Drug Manufacturing production by Application production, value, CAGR, 2018-2029, (USD Million) & (K MT)
This reports profiles key players in the global Biological API Drug Manufacturing market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM, Samsung BioLogics, Fujifilm Diosynth Biotechnologies, Cytovance Biologics, AbbVie and Baxter, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological API Drug Manufacturing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biological API Drug Manufacturing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Biological API Drug Manufacturing Market, Segmentation by Type
In-House manufacturing
Contract manufacturing

Global Biological API Drug Manufacturing Market, Segmentation by Application
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other

Companies Profiled:
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics

Key Questions Answered
1. How big is the global Biological API Drug Manufacturing market?
2. What is the demand of the global Biological API Drug Manufacturing market?
3. What is the year over year growth of the global Biological API Drug Manufacturing market?
4. What is the production and production value of the global Biological API Drug Manufacturing market?
5. Who are the key producers in the global Biological API Drug Manufacturing market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Biological API Drug Manufacturing Introduction
1.2 World Biological API Drug Manufacturing Supply & Forecast
1.2.1 World Biological API Drug Manufacturing Production Value (2018 & 2022 & 2029)
1.2.2 World Biological API Drug Manufacturing Production (2018-2029)
1.2.3 World Biological API Drug Manufacturing Pricing Trends (2018-2029)
1.3 World Biological API Drug Manufacturing Production by Region (Based on Production Site)
1.3.1 World Biological API Drug Manufacturing Production Value by Region (2018-2029)
1.3.2 World Biological API Drug Manufacturing Production by Region (2018-2029)
1.3.3 World Biological API Drug Manufacturing Average Price by Region (2018-2029)
1.3.4 North America Biological API Drug Manufacturing Production (2018-2029)
1.3.5 Europe Biological API Drug Manufacturing Production (2018-2029)
1.3.6 China Biological API Drug Manufacturing Production (2018-2029)
1.3.7 Japan Biological API Drug Manufacturing Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological API Drug Manufacturing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological API Drug Manufacturing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Biological API Drug Manufacturing Demand (2018-2029)
2.2 World Biological API Drug Manufacturing Consumption by Region
2.2.1 World Biological API Drug Manufacturing Consumption by Region (2018-2023)
2.2.2 World Biological API Drug Manufacturing Consumption Forecast by Region (2024-2029)
2.3 United States Biological API Drug Manufacturing Consumption (2018-2029)
2.4 China Biological API Drug Manufacturing Consumption (2018-2029)
2.5 Europe Biological API Drug Manufacturing Consumption (2018-2029)
2.6 Japan Biological API Drug Manufacturing Consumption (2018-2029)
2.7 South Korea Biological API Drug Manufacturing Consumption (2018-2029)
2.8 ASEAN Biological API Drug Manufacturing Consumption (2018-2029)
2.9 India Biological API Drug Manufacturing Consumption (2018-2029)

3 World Biological API Drug Manufacturing Manufacturers Competitive Analysis
3.1 World Biological API Drug Manufacturing Production Value by Manufacturer (2018-2023)
3.2 World Biological API Drug Manufacturing Production by Manufacturer (2018-2023)
3.3 World Biological API Drug Manufacturing Average Price by Manufacturer (2018-2023)
3.4 Biological API Drug Manufacturing Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological API Drug Manufacturing Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological API Drug Manufacturing in 2022
3.5.3 Global Concentration Ratios (CR8) for Biological API Drug Manufacturing in 2022
3.6 Biological API Drug Manufacturing Market: Overall Company Footprint Analysis
3.6.1 Biological API Drug Manufacturing Market: Region Footprint
3.6.2 Biological API Drug Manufacturing Market: Company Product Type Footprint
3.6.3 Biological API Drug Manufacturing Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Biological API Drug Manufacturing Production Value Comparison
4.1.1 United States VS China: Biological API Drug Manufacturing Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biological API Drug Manufacturing Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biological API Drug Manufacturing Production Comparison
4.2.1 United States VS China: Biological API Drug Manufacturing Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological API Drug Manufacturing Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biological API Drug Manufacturing Consumption Comparison
4.3.1 United States VS China: Biological API Drug Manufacturing Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biological API Drug Manufacturing Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biological API Drug Manufacturing Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biological API Drug Manufacturing Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biological API Drug Manufacturing Production (2018-2023)
4.5 China Based Biological API Drug Manufacturing Manufacturers and Market Share
4.5.1 China Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biological API Drug Manufacturing Production Value (2018-2023)
4.5.3 China Based Manufacturers Biological API Drug Manufacturing Production (2018-2023)
4.6 Rest of World Based Biological API Drug Manufacturing Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biological API Drug Manufacturing Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biological API Drug Manufacturing Production (2018-2023)

5 Market Analysis by Type
5.1 World Biological API Drug Manufacturing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 In-House manufacturing
5.2.2 Contract manufacturing
5.3 Market Segment by Type
5.3.1 World Biological API Drug Manufacturing Production by Type (2018-2029)
5.3.2 World Biological API Drug Manufacturing Production Value by Type (2018-2029)
5.3.3 World Biological API Drug Manufacturing Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Biological API Drug Manufacturing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Monoclonal Antibody (mAb) Therapies
6.2.2 Vaccines
6.2.3 Insulin Therapies
6.2.4 Interferon Therapies
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Biological API Drug Manufacturing Production by Application (2018-2029)
6.3.2 World Biological API Drug Manufacturing Production Value by Application (2018-2029)
6.3.3 World Biological API Drug Manufacturing Average Price by Application (2018-2029)

7 Company Profiles
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biological API Drug Manufacturing Product and Services
7.1.4 Lonza Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Boehringer Ingelheim BioXcellence
7.2.1 Boehringer Ingelheim BioXcellence Details
7.2.2 Boehringer Ingelheim BioXcellence Major Business
7.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product and Services
7.2.4 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer Ingelheim BioXcellence Recent Developments/Updates
7.2.6 Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
7.3 Celltrion
7.3.1 Celltrion Details
7.3.2 Celltrion Major Business
7.3.3 Celltrion Biological API Drug Manufacturing Product and Services
7.3.4 Celltrion Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Celltrion Recent Developments/Updates
7.3.6 Celltrion Competitive Strengths & Weaknesses
7.4 DSM
7.4.1 DSM Details
7.4.2 DSM Major Business
7.4.3 DSM Biological API Drug Manufacturing Product and Services
7.4.4 DSM Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 DSM Recent Developments/Updates
7.4.6 DSM Competitive Strengths & Weaknesses
7.5 Samsung BioLogics
7.5.1 Samsung BioLogics Details
7.5.2 Samsung BioLogics Major Business
7.5.3 Samsung BioLogics Biological API Drug Manufacturing Product and Services
7.5.4 Samsung BioLogics Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Samsung BioLogics Recent Developments/Updates
7.5.6 Samsung BioLogics Competitive Strengths & Weaknesses
7.6 Fujifilm Diosynth Biotechnologies
7.6.1 Fujifilm Diosynth Biotechnologies Details
7.6.2 Fujifilm Diosynth Biotechnologies Major Business
7.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product and Services
7.6.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
7.6.6 Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.7 Cytovance Biologics
7.7.1 Cytovance Biologics Details
7.7.2 Cytovance Biologics Major Business
7.7.3 Cytovance Biologics Biological API Drug Manufacturing Product and Services
7.7.4 Cytovance Biologics Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Cytovance Biologics Recent Developments/Updates
7.7.6 Cytovance Biologics Competitive Strengths & Weaknesses
7.8 AbbVie
7.8.1 AbbVie Details
7.8.2 AbbVie Major Business
7.8.3 AbbVie Biological API Drug Manufacturing Product and Services
7.8.4 AbbVie Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AbbVie Recent Developments/Updates
7.8.6 AbbVie Competitive Strengths & Weaknesses
7.9 Baxter
7.9.1 Baxter Details
7.9.2 Baxter Major Business
7.9.3 Baxter Biological API Drug Manufacturing Product and Services
7.9.4 Baxter Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Baxter Recent Developments/Updates
7.9.6 Baxter Competitive Strengths & Weaknesses
7.10 CEPiA Sanofi
7.10.1 CEPiA Sanofi Details
7.10.2 CEPiA Sanofi Major Business
7.10.3 CEPiA Sanofi Biological API Drug Manufacturing Product and Services
7.10.4 CEPiA Sanofi Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 CEPiA Sanofi Recent Developments/Updates
7.10.6 CEPiA Sanofi Competitive Strengths & Weaknesses
7.11 GSK
7.11.1 GSK Details
7.11.2 GSK Major Business
7.11.3 GSK Biological API Drug Manufacturing Product and Services
7.11.4 GSK Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 GSK Recent Developments/Updates
7.11.6 GSK Competitive Strengths & Weaknesses
7.12 Pfizer CentreOne
7.12.1 Pfizer CentreOne Details
7.12.2 Pfizer CentreOne Major Business
7.12.3 Pfizer CentreOne Biological API Drug Manufacturing Product and Services
7.12.4 Pfizer CentreOne Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pfizer CentreOne Recent Developments/Updates
7.12.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.13 Sandoz
7.13.1 Sandoz Details
7.13.2 Sandoz Major Business
7.13.3 Sandoz Biological API Drug Manufacturing Product and Services
7.13.4 Sandoz Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sandoz Recent Developments/Updates
7.13.6 Sandoz Competitive Strengths & Weaknesses
7.14 Vetter
7.14.1 Vetter Details
7.14.2 Vetter Major Business
7.14.3 Vetter Biological API Drug Manufacturing Product and Services
7.14.4 Vetter Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Vetter Recent Developments/Updates
7.14.6 Vetter Competitive Strengths & Weaknesses
7.15 Wuxi Biologics
7.15.1 Wuxi Biologics Details
7.15.2 Wuxi Biologics Major Business
7.15.3 Wuxi Biologics Biological API Drug Manufacturing Product and Services
7.15.4 Wuxi Biologics Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Wuxi Biologics Recent Developments/Updates
7.15.6 Wuxi Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Biological API Drug Manufacturing Industry Chain
8.2 Biological API Drug Manufacturing Upstream Analysis
8.2.1 Biological API Drug Manufacturing Core Raw Materials
8.2.2 Main Manufacturers of Biological API Drug Manufacturing Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biological API Drug Manufacturing Production Mode
8.6 Biological API Drug Manufacturing Procurement Model
8.7 Biological API Drug Manufacturing Industry Sales Model and Sales Channels
8.7.1 Biological API Drug Manufacturing Sales Model
8.7.2 Biological API Drug Manufacturing Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Biological API Drug Manufacturing Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biological API Drug Manufacturing Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biological API Drug Manufacturing Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biological API Drug Manufacturing Production Value Market Share by Region (2018-2023)
Table 5. World Biological API Drug Manufacturing Production Value Market Share by Region (2024-2029)
Table 6. World Biological API Drug Manufacturing Production by Region (2018-2023) & (K MT)
Table 7. World Biological API Drug Manufacturing Production by Region (2024-2029) & (K MT)
Table 8. World Biological API Drug Manufacturing Production Market Share by Region (2018-2023)
Table 9. World Biological API Drug Manufacturing Production Market Share by Region (2024-2029)
Table 10. World Biological API Drug Manufacturing Average Price by Region (2018-2023) & (USD/MT)
Table 11. World Biological API Drug Manufacturing Average Price by Region (2024-2029) & (USD/MT)
Table 12. Biological API Drug Manufacturing Major Market Trends
Table 13. World Biological API Drug Manufacturing Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K MT)
Table 14. World Biological API Drug Manufacturing Consumption by Region (2018-2023) & (K MT)
Table 15. World Biological API Drug Manufacturing Consumption Forecast by Region (2024-2029) & (K MT)
Table 16. World Biological API Drug Manufacturing Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biological API Drug Manufacturing Producers in 2022
Table 18. World Biological API Drug Manufacturing Production by Manufacturer (2018-2023) & (K MT)
Table 19. Production Market Share of Key Biological API Drug Manufacturing Producers in 2022
Table 20. World Biological API Drug Manufacturing Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 21. Global Biological API Drug Manufacturing Company Evaluation Quadrant
Table 22. World Biological API Drug Manufacturing Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biological API Drug Manufacturing Production Site of Key Manufacturer
Table 24. Biological API Drug Manufacturing Market: Company Product Type Footprint
Table 25. Biological API Drug Manufacturing Market: Company Product Application Footprint
Table 26. Biological API Drug Manufacturing Competitive Factors
Table 27. Biological API Drug Manufacturing New Entrant and Capacity Expansion Plans
Table 28. Biological API Drug Manufacturing Mergers & Acquisitions Activity
Table 29. United States VS China Biological API Drug Manufacturing Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biological API Drug Manufacturing Production Comparison, (2018 & 2022 & 2029) & (K MT)
Table 31. United States VS China Biological API Drug Manufacturing Consumption Comparison, (2018 & 2022 & 2029) & (K MT)
Table 32. United States Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biological API Drug Manufacturing Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biological API Drug Manufacturing Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biological API Drug Manufacturing Production (2018-2023) & (K MT)
Table 36. United States Based Manufacturers Biological API Drug Manufacturing Production Market Share (2018-2023)
Table 37. China Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biological API Drug Manufacturing Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biological API Drug Manufacturing Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biological API Drug Manufacturing Production (2018-2023) & (K MT)
Table 41. China Based Manufacturers Biological API Drug Manufacturing Production Market Share (2018-2023)
Table 42. Rest of World Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biological API Drug Manufacturing Production (2018-2023) & (K MT)
Table 46. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Market Share (2018-2023)
Table 47. World Biological API Drug Manufacturing Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biological API Drug Manufacturing Production by Type (2018-2023) & (K MT)
Table 49. World Biological API Drug Manufacturing Production by Type (2024-2029) & (K MT)
Table 50. World Biological API Drug Manufacturing Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biological API Drug Manufacturing Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biological API Drug Manufacturing Average Price by Type (2018-2023) & (USD/MT)
Table 53. World Biological API Drug Manufacturing Average Price by Type (2024-2029) & (USD/MT)
Table 54. World Biological API Drug Manufacturing Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biological API Drug Manufacturing Production by Application (2018-2023) & (K MT)
Table 56. World Biological API Drug Manufacturing Production by Application (2024-2029) & (K MT)
Table 57. World Biological API Drug Manufacturing Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biological API Drug Manufacturing Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biological API Drug Manufacturing Average Price by Application (2018-2023) & (USD/MT)
Table 60. World Biological API Drug Manufacturing Average Price by Application (2024-2029) & (USD/MT)
Table 61. Lonza Basic Information, Manufacturing Base and Competitors
Table 62. Lonza Major Business
Table 63. Lonza Biological API Drug Manufacturing Product and Services
Table 64. Lonza Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Lonza Recent Developments/Updates
Table 66. Lonza Competitive Strengths & Weaknesses
Table 67. Boehringer Ingelheim BioXcellence Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim BioXcellence Major Business
Table 69. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product and Services
Table 70. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer Ingelheim BioXcellence Recent Developments/Updates
Table 72. Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
Table 73. Celltrion Basic Information, Manufacturing Base and Competitors
Table 74. Celltrion Major Business
Table 75. Celltrion Biological API Drug Manufacturing Product and Services
Table 76. Celltrion Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Celltrion Recent Developments/Updates
Table 78. Celltrion Competitive Strengths & Weaknesses
Table 79. DSM Basic Information, Manufacturing Base and Competitors
Table 80. DSM Major Business
Table 81. DSM Biological API Drug Manufacturing Product and Services
Table 82. DSM Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. DSM Recent Developments/Updates
Table 84. DSM Competitive Strengths & Weaknesses
Table 85. Samsung BioLogics Basic Information, Manufacturing Base and Competitors
Table 86. Samsung BioLogics Major Business
Table 87. Samsung BioLogics Biological API Drug Manufacturing Product and Services
Table 88. Samsung BioLogics Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Samsung BioLogics Recent Developments/Updates
Table 90. Samsung BioLogics Competitive Strengths & Weaknesses
Table 91. Fujifilm Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 92. Fujifilm Diosynth Biotechnologies Major Business
Table 93. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product and Services
Table 94. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Fujifilm Diosynth Biotechnologies Recent Developments/Updates
Table 96. Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 97. Cytovance Biologics Basic Information, Manufacturing Base and Competitors
Table 98. Cytovance Biologics Major Business
Table 99. Cytovance Biologics Biological API Drug Manufacturing Product and Services
Table 100. Cytovance Biologics Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Cytovance Biologics Recent Developments/Updates
Table 102. Cytovance Biologics Competitive Strengths & Weaknesses
Table 103. AbbVie Basic Information, Manufacturing Base and Competitors
Table 104. AbbVie Major Business
Table 105. AbbVie Biological API Drug Manufacturing Product and Services
Table 106. AbbVie Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AbbVie Recent Developments/Updates
Table 108. AbbVie Competitive Strengths & Weaknesses
Table 109. Baxter Basic Information, Manufacturing Base and Competitors
Table 110. Baxter Major Business
Table 111. Baxter Biological API Drug Manufacturing Product and Services
Table 112. Baxter Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Baxter Recent Developments/Updates
Table 114. Baxter Competitive Strengths & Weaknesses
Table 115. CEPiA Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. CEPiA Sanofi Major Business
Table 117. CEPiA Sanofi Biological API Drug Manufacturing Product and Services
Table 118. CEPiA Sanofi Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. CEPiA Sanofi Recent Developments/Updates
Table 120. CEPiA Sanofi Competitive Strengths & Weaknesses
Table 121. GSK Basic Information, Manufacturing Base and Competitors
Table 122. GSK Major Business
Table 123. GSK Biological API Drug Manufacturing Product and Services
Table 124. GSK Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. GSK Recent Developments/Updates
Table 126. GSK Competitive Strengths & Weaknesses
Table 127. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 128. Pfizer CentreOne Major Business
Table 129. Pfizer CentreOne Biological API Drug Manufacturing Product and Services
Table 130. Pfizer CentreOne Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer CentreOne Recent Developments/Updates
Table 132. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 133. Sandoz Basic Information, Manufacturing Base and Competitors
Table 134. Sandoz Major Business
Table 135. Sandoz Biological API Drug Manufacturing Product and Services
Table 136. Sandoz Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sandoz Recent Developments/Updates
Table 138. Sandoz Competitive Strengths & Weaknesses
Table 139. Vetter Basic Information, Manufacturing Base and Competitors
Table 140. Vetter Major Business
Table 141. Vetter Biological API Drug Manufacturing Product and Services
Table 142. Vetter Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Vetter Recent Developments/Updates
Table 144. Wuxi Biologics Basic Information, Manufacturing Base and Competitors
Table 145. Wuxi Biologics Major Business
Table 146. Wuxi Biologics Biological API Drug Manufacturing Product and Services
Table 147. Wuxi Biologics Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Biological API Drug Manufacturing Upstream (Raw Materials)
Table 149. Biological API Drug Manufacturing Typical Customers
Table 150. Biological API Drug Manufacturing Typical Distributors
List of Figure
Figure 1. Biological API Drug Manufacturing Picture
Figure 2. World Biological API Drug Manufacturing Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological API Drug Manufacturing Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 5. World Biological API Drug Manufacturing Average Price (2018-2029) & (USD/MT)
Figure 6. World Biological API Drug Manufacturing Production Value Market Share by Region (2018-2029)
Figure 7. World Biological API Drug Manufacturing Production Market Share by Region (2018-2029)
Figure 8. North America Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 9. Europe Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 10. China Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 11. Japan Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 12. Biological API Drug Manufacturing Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 15. World Biological API Drug Manufacturing Consumption Market Share by Region (2018-2029)
Figure 16. United States Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 17. China Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 18. Europe Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 19. Japan Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 20. South Korea Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 21. ASEAN Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 22. India Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 23. Producer Shipments of Biological API Drug Manufacturing by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological API Drug Manufacturing Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological API Drug Manufacturing Markets in 2022
Figure 26. United States VS China: Biological API Drug Manufacturing Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biological API Drug Manufacturing Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological API Drug Manufacturing Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biological API Drug Manufacturing Production Market Share 2022
Figure 30. China Based Manufacturers Biological API Drug Manufacturing Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Market Share 2022
Figure 32. World Biological API Drug Manufacturing Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biological API Drug Manufacturing Production Value Market Share by Type in 2022
Figure 34. In-House manufacturing
Figure 35. Contract manufacturing
Figure 36. World Biological API Drug Manufacturing Production Market Share by Type (2018-2029)
Figure 37. World Biological API Drug Manufacturing Production Value Market Share by Type (2018-2029)
Figure 38. World Biological API Drug Manufacturing Average Price by Type (2018-2029) & (USD/MT)
Figure 39. World Biological API Drug Manufacturing Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Biological API Drug Manufacturing Production Value Market Share by Application in 2022
Figure 41. Monoclonal Antibody (mAb) Therapies
Figure 42. Vaccines
Figure 43. Insulin Therapies
Figure 44. Interferon Therapies
Figure 45. Other
Figure 46. World Biological API Drug Manufacturing Production Market Share by Application (2018-2029)
Figure 47. World Biological API Drug Manufacturing Production Value Market Share by Application (2018-2029)
Figure 48. World Biological API Drug Manufacturing Average Price by Application (2018-2029) & (USD/MT)
Figure 49. Biological API Drug Manufacturing Industry Chain
Figure 50. Biological API Drug Manufacturing Procurement Model
Figure 51. Biological API Drug Manufacturing Sales Model
Figure 52. Biological API Drug Manufacturing Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Biological API Drug Manufacturing Supply, Demand and Key Producers, 2023-2029

Global Biological API Drug Manufacturing Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 14 Mar 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.

This report studies the global Biological API Drug Manufacturing production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biological API Drug Manufacturing, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological API Drug Manufacturing that contribute to its increasing demand across many markets.

The global Biological API Drug Manufacturing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Biological API Drug Manufacturing total production and demand, 2018-2029, (K MT)
Global Biological API Drug Manufacturing total production value, 2018-2029, (USD Million)
Global Biological API Drug Manufacturing production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Biological API Drug Manufacturing consumption by region & country, CAGR, 2018-2029 & (K MT)
U.S. VS China: Biological API Drug Manufacturing domestic production, consumption, key domestic manufacturers and share
Global Biological API Drug Manufacturing production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K MT)
Global Biological API Drug Manufacturing production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Biological API Drug Manufacturing production by Application production, value, CAGR, 2018-2029, (USD Million) & (K MT)
This reports profiles key players in the global Biological API Drug Manufacturing market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM, Samsung BioLogics, Fujifilm Diosynth Biotechnologies, Cytovance Biologics, AbbVie and Baxter, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological API Drug Manufacturing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biological API Drug Manufacturing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Biological API Drug Manufacturing Market, Segmentation by Type
In-House manufacturing
Contract manufacturing

Global Biological API Drug Manufacturing Market, Segmentation by Application
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other

Companies Profiled:
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics

Key Questions Answered
1. How big is the global Biological API Drug Manufacturing market?
2. What is the demand of the global Biological API Drug Manufacturing market?
3. What is the year over year growth of the global Biological API Drug Manufacturing market?
4. What is the production and production value of the global Biological API Drug Manufacturing market?
5. Who are the key producers in the global Biological API Drug Manufacturing market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Biological API Drug Manufacturing Introduction
1.2 World Biological API Drug Manufacturing Supply & Forecast
1.2.1 World Biological API Drug Manufacturing Production Value (2018 & 2022 & 2029)
1.2.2 World Biological API Drug Manufacturing Production (2018-2029)
1.2.3 World Biological API Drug Manufacturing Pricing Trends (2018-2029)
1.3 World Biological API Drug Manufacturing Production by Region (Based on Production Site)
1.3.1 World Biological API Drug Manufacturing Production Value by Region (2018-2029)
1.3.2 World Biological API Drug Manufacturing Production by Region (2018-2029)
1.3.3 World Biological API Drug Manufacturing Average Price by Region (2018-2029)
1.3.4 North America Biological API Drug Manufacturing Production (2018-2029)
1.3.5 Europe Biological API Drug Manufacturing Production (2018-2029)
1.3.6 China Biological API Drug Manufacturing Production (2018-2029)
1.3.7 Japan Biological API Drug Manufacturing Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological API Drug Manufacturing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological API Drug Manufacturing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Biological API Drug Manufacturing Demand (2018-2029)
2.2 World Biological API Drug Manufacturing Consumption by Region
2.2.1 World Biological API Drug Manufacturing Consumption by Region (2018-2023)
2.2.2 World Biological API Drug Manufacturing Consumption Forecast by Region (2024-2029)
2.3 United States Biological API Drug Manufacturing Consumption (2018-2029)
2.4 China Biological API Drug Manufacturing Consumption (2018-2029)
2.5 Europe Biological API Drug Manufacturing Consumption (2018-2029)
2.6 Japan Biological API Drug Manufacturing Consumption (2018-2029)
2.7 South Korea Biological API Drug Manufacturing Consumption (2018-2029)
2.8 ASEAN Biological API Drug Manufacturing Consumption (2018-2029)
2.9 India Biological API Drug Manufacturing Consumption (2018-2029)

3 World Biological API Drug Manufacturing Manufacturers Competitive Analysis
3.1 World Biological API Drug Manufacturing Production Value by Manufacturer (2018-2023)
3.2 World Biological API Drug Manufacturing Production by Manufacturer (2018-2023)
3.3 World Biological API Drug Manufacturing Average Price by Manufacturer (2018-2023)
3.4 Biological API Drug Manufacturing Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological API Drug Manufacturing Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological API Drug Manufacturing in 2022
3.5.3 Global Concentration Ratios (CR8) for Biological API Drug Manufacturing in 2022
3.6 Biological API Drug Manufacturing Market: Overall Company Footprint Analysis
3.6.1 Biological API Drug Manufacturing Market: Region Footprint
3.6.2 Biological API Drug Manufacturing Market: Company Product Type Footprint
3.6.3 Biological API Drug Manufacturing Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Biological API Drug Manufacturing Production Value Comparison
4.1.1 United States VS China: Biological API Drug Manufacturing Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biological API Drug Manufacturing Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biological API Drug Manufacturing Production Comparison
4.2.1 United States VS China: Biological API Drug Manufacturing Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological API Drug Manufacturing Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biological API Drug Manufacturing Consumption Comparison
4.3.1 United States VS China: Biological API Drug Manufacturing Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biological API Drug Manufacturing Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biological API Drug Manufacturing Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biological API Drug Manufacturing Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biological API Drug Manufacturing Production (2018-2023)
4.5 China Based Biological API Drug Manufacturing Manufacturers and Market Share
4.5.1 China Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biological API Drug Manufacturing Production Value (2018-2023)
4.5.3 China Based Manufacturers Biological API Drug Manufacturing Production (2018-2023)
4.6 Rest of World Based Biological API Drug Manufacturing Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biological API Drug Manufacturing Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biological API Drug Manufacturing Production (2018-2023)

5 Market Analysis by Type
5.1 World Biological API Drug Manufacturing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 In-House manufacturing
5.2.2 Contract manufacturing
5.3 Market Segment by Type
5.3.1 World Biological API Drug Manufacturing Production by Type (2018-2029)
5.3.2 World Biological API Drug Manufacturing Production Value by Type (2018-2029)
5.3.3 World Biological API Drug Manufacturing Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Biological API Drug Manufacturing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Monoclonal Antibody (mAb) Therapies
6.2.2 Vaccines
6.2.3 Insulin Therapies
6.2.4 Interferon Therapies
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Biological API Drug Manufacturing Production by Application (2018-2029)
6.3.2 World Biological API Drug Manufacturing Production Value by Application (2018-2029)
6.3.3 World Biological API Drug Manufacturing Average Price by Application (2018-2029)

7 Company Profiles
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biological API Drug Manufacturing Product and Services
7.1.4 Lonza Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Boehringer Ingelheim BioXcellence
7.2.1 Boehringer Ingelheim BioXcellence Details
7.2.2 Boehringer Ingelheim BioXcellence Major Business
7.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product and Services
7.2.4 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer Ingelheim BioXcellence Recent Developments/Updates
7.2.6 Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
7.3 Celltrion
7.3.1 Celltrion Details
7.3.2 Celltrion Major Business
7.3.3 Celltrion Biological API Drug Manufacturing Product and Services
7.3.4 Celltrion Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Celltrion Recent Developments/Updates
7.3.6 Celltrion Competitive Strengths & Weaknesses
7.4 DSM
7.4.1 DSM Details
7.4.2 DSM Major Business
7.4.3 DSM Biological API Drug Manufacturing Product and Services
7.4.4 DSM Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 DSM Recent Developments/Updates
7.4.6 DSM Competitive Strengths & Weaknesses
7.5 Samsung BioLogics
7.5.1 Samsung BioLogics Details
7.5.2 Samsung BioLogics Major Business
7.5.3 Samsung BioLogics Biological API Drug Manufacturing Product and Services
7.5.4 Samsung BioLogics Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Samsung BioLogics Recent Developments/Updates
7.5.6 Samsung BioLogics Competitive Strengths & Weaknesses
7.6 Fujifilm Diosynth Biotechnologies
7.6.1 Fujifilm Diosynth Biotechnologies Details
7.6.2 Fujifilm Diosynth Biotechnologies Major Business
7.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product and Services
7.6.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
7.6.6 Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.7 Cytovance Biologics
7.7.1 Cytovance Biologics Details
7.7.2 Cytovance Biologics Major Business
7.7.3 Cytovance Biologics Biological API Drug Manufacturing Product and Services
7.7.4 Cytovance Biologics Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Cytovance Biologics Recent Developments/Updates
7.7.6 Cytovance Biologics Competitive Strengths & Weaknesses
7.8 AbbVie
7.8.1 AbbVie Details
7.8.2 AbbVie Major Business
7.8.3 AbbVie Biological API Drug Manufacturing Product and Services
7.8.4 AbbVie Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AbbVie Recent Developments/Updates
7.8.6 AbbVie Competitive Strengths & Weaknesses
7.9 Baxter
7.9.1 Baxter Details
7.9.2 Baxter Major Business
7.9.3 Baxter Biological API Drug Manufacturing Product and Services
7.9.4 Baxter Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Baxter Recent Developments/Updates
7.9.6 Baxter Competitive Strengths & Weaknesses
7.10 CEPiA Sanofi
7.10.1 CEPiA Sanofi Details
7.10.2 CEPiA Sanofi Major Business
7.10.3 CEPiA Sanofi Biological API Drug Manufacturing Product and Services
7.10.4 CEPiA Sanofi Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 CEPiA Sanofi Recent Developments/Updates
7.10.6 CEPiA Sanofi Competitive Strengths & Weaknesses
7.11 GSK
7.11.1 GSK Details
7.11.2 GSK Major Business
7.11.3 GSK Biological API Drug Manufacturing Product and Services
7.11.4 GSK Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 GSK Recent Developments/Updates
7.11.6 GSK Competitive Strengths & Weaknesses
7.12 Pfizer CentreOne
7.12.1 Pfizer CentreOne Details
7.12.2 Pfizer CentreOne Major Business
7.12.3 Pfizer CentreOne Biological API Drug Manufacturing Product and Services
7.12.4 Pfizer CentreOne Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pfizer CentreOne Recent Developments/Updates
7.12.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.13 Sandoz
7.13.1 Sandoz Details
7.13.2 Sandoz Major Business
7.13.3 Sandoz Biological API Drug Manufacturing Product and Services
7.13.4 Sandoz Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sandoz Recent Developments/Updates
7.13.6 Sandoz Competitive Strengths & Weaknesses
7.14 Vetter
7.14.1 Vetter Details
7.14.2 Vetter Major Business
7.14.3 Vetter Biological API Drug Manufacturing Product and Services
7.14.4 Vetter Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Vetter Recent Developments/Updates
7.14.6 Vetter Competitive Strengths & Weaknesses
7.15 Wuxi Biologics
7.15.1 Wuxi Biologics Details
7.15.2 Wuxi Biologics Major Business
7.15.3 Wuxi Biologics Biological API Drug Manufacturing Product and Services
7.15.4 Wuxi Biologics Biological API Drug Manufacturing Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Wuxi Biologics Recent Developments/Updates
7.15.6 Wuxi Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Biological API Drug Manufacturing Industry Chain
8.2 Biological API Drug Manufacturing Upstream Analysis
8.2.1 Biological API Drug Manufacturing Core Raw Materials
8.2.2 Main Manufacturers of Biological API Drug Manufacturing Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biological API Drug Manufacturing Production Mode
8.6 Biological API Drug Manufacturing Procurement Model
8.7 Biological API Drug Manufacturing Industry Sales Model and Sales Channels
8.7.1 Biological API Drug Manufacturing Sales Model
8.7.2 Biological API Drug Manufacturing Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Biological API Drug Manufacturing Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biological API Drug Manufacturing Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biological API Drug Manufacturing Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biological API Drug Manufacturing Production Value Market Share by Region (2018-2023)
Table 5. World Biological API Drug Manufacturing Production Value Market Share by Region (2024-2029)
Table 6. World Biological API Drug Manufacturing Production by Region (2018-2023) & (K MT)
Table 7. World Biological API Drug Manufacturing Production by Region (2024-2029) & (K MT)
Table 8. World Biological API Drug Manufacturing Production Market Share by Region (2018-2023)
Table 9. World Biological API Drug Manufacturing Production Market Share by Region (2024-2029)
Table 10. World Biological API Drug Manufacturing Average Price by Region (2018-2023) & (USD/MT)
Table 11. World Biological API Drug Manufacturing Average Price by Region (2024-2029) & (USD/MT)
Table 12. Biological API Drug Manufacturing Major Market Trends
Table 13. World Biological API Drug Manufacturing Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K MT)
Table 14. World Biological API Drug Manufacturing Consumption by Region (2018-2023) & (K MT)
Table 15. World Biological API Drug Manufacturing Consumption Forecast by Region (2024-2029) & (K MT)
Table 16. World Biological API Drug Manufacturing Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biological API Drug Manufacturing Producers in 2022
Table 18. World Biological API Drug Manufacturing Production by Manufacturer (2018-2023) & (K MT)
Table 19. Production Market Share of Key Biological API Drug Manufacturing Producers in 2022
Table 20. World Biological API Drug Manufacturing Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 21. Global Biological API Drug Manufacturing Company Evaluation Quadrant
Table 22. World Biological API Drug Manufacturing Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biological API Drug Manufacturing Production Site of Key Manufacturer
Table 24. Biological API Drug Manufacturing Market: Company Product Type Footprint
Table 25. Biological API Drug Manufacturing Market: Company Product Application Footprint
Table 26. Biological API Drug Manufacturing Competitive Factors
Table 27. Biological API Drug Manufacturing New Entrant and Capacity Expansion Plans
Table 28. Biological API Drug Manufacturing Mergers & Acquisitions Activity
Table 29. United States VS China Biological API Drug Manufacturing Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biological API Drug Manufacturing Production Comparison, (2018 & 2022 & 2029) & (K MT)
Table 31. United States VS China Biological API Drug Manufacturing Consumption Comparison, (2018 & 2022 & 2029) & (K MT)
Table 32. United States Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biological API Drug Manufacturing Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biological API Drug Manufacturing Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biological API Drug Manufacturing Production (2018-2023) & (K MT)
Table 36. United States Based Manufacturers Biological API Drug Manufacturing Production Market Share (2018-2023)
Table 37. China Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biological API Drug Manufacturing Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biological API Drug Manufacturing Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biological API Drug Manufacturing Production (2018-2023) & (K MT)
Table 41. China Based Manufacturers Biological API Drug Manufacturing Production Market Share (2018-2023)
Table 42. Rest of World Based Biological API Drug Manufacturing Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biological API Drug Manufacturing Production (2018-2023) & (K MT)
Table 46. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Market Share (2018-2023)
Table 47. World Biological API Drug Manufacturing Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biological API Drug Manufacturing Production by Type (2018-2023) & (K MT)
Table 49. World Biological API Drug Manufacturing Production by Type (2024-2029) & (K MT)
Table 50. World Biological API Drug Manufacturing Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biological API Drug Manufacturing Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biological API Drug Manufacturing Average Price by Type (2018-2023) & (USD/MT)
Table 53. World Biological API Drug Manufacturing Average Price by Type (2024-2029) & (USD/MT)
Table 54. World Biological API Drug Manufacturing Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biological API Drug Manufacturing Production by Application (2018-2023) & (K MT)
Table 56. World Biological API Drug Manufacturing Production by Application (2024-2029) & (K MT)
Table 57. World Biological API Drug Manufacturing Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biological API Drug Manufacturing Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biological API Drug Manufacturing Average Price by Application (2018-2023) & (USD/MT)
Table 60. World Biological API Drug Manufacturing Average Price by Application (2024-2029) & (USD/MT)
Table 61. Lonza Basic Information, Manufacturing Base and Competitors
Table 62. Lonza Major Business
Table 63. Lonza Biological API Drug Manufacturing Product and Services
Table 64. Lonza Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Lonza Recent Developments/Updates
Table 66. Lonza Competitive Strengths & Weaknesses
Table 67. Boehringer Ingelheim BioXcellence Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim BioXcellence Major Business
Table 69. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product and Services
Table 70. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer Ingelheim BioXcellence Recent Developments/Updates
Table 72. Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
Table 73. Celltrion Basic Information, Manufacturing Base and Competitors
Table 74. Celltrion Major Business
Table 75. Celltrion Biological API Drug Manufacturing Product and Services
Table 76. Celltrion Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Celltrion Recent Developments/Updates
Table 78. Celltrion Competitive Strengths & Weaknesses
Table 79. DSM Basic Information, Manufacturing Base and Competitors
Table 80. DSM Major Business
Table 81. DSM Biological API Drug Manufacturing Product and Services
Table 82. DSM Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. DSM Recent Developments/Updates
Table 84. DSM Competitive Strengths & Weaknesses
Table 85. Samsung BioLogics Basic Information, Manufacturing Base and Competitors
Table 86. Samsung BioLogics Major Business
Table 87. Samsung BioLogics Biological API Drug Manufacturing Product and Services
Table 88. Samsung BioLogics Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Samsung BioLogics Recent Developments/Updates
Table 90. Samsung BioLogics Competitive Strengths & Weaknesses
Table 91. Fujifilm Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 92. Fujifilm Diosynth Biotechnologies Major Business
Table 93. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product and Services
Table 94. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Fujifilm Diosynth Biotechnologies Recent Developments/Updates
Table 96. Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 97. Cytovance Biologics Basic Information, Manufacturing Base and Competitors
Table 98. Cytovance Biologics Major Business
Table 99. Cytovance Biologics Biological API Drug Manufacturing Product and Services
Table 100. Cytovance Biologics Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Cytovance Biologics Recent Developments/Updates
Table 102. Cytovance Biologics Competitive Strengths & Weaknesses
Table 103. AbbVie Basic Information, Manufacturing Base and Competitors
Table 104. AbbVie Major Business
Table 105. AbbVie Biological API Drug Manufacturing Product and Services
Table 106. AbbVie Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AbbVie Recent Developments/Updates
Table 108. AbbVie Competitive Strengths & Weaknesses
Table 109. Baxter Basic Information, Manufacturing Base and Competitors
Table 110. Baxter Major Business
Table 111. Baxter Biological API Drug Manufacturing Product and Services
Table 112. Baxter Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Baxter Recent Developments/Updates
Table 114. Baxter Competitive Strengths & Weaknesses
Table 115. CEPiA Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. CEPiA Sanofi Major Business
Table 117. CEPiA Sanofi Biological API Drug Manufacturing Product and Services
Table 118. CEPiA Sanofi Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. CEPiA Sanofi Recent Developments/Updates
Table 120. CEPiA Sanofi Competitive Strengths & Weaknesses
Table 121. GSK Basic Information, Manufacturing Base and Competitors
Table 122. GSK Major Business
Table 123. GSK Biological API Drug Manufacturing Product and Services
Table 124. GSK Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. GSK Recent Developments/Updates
Table 126. GSK Competitive Strengths & Weaknesses
Table 127. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 128. Pfizer CentreOne Major Business
Table 129. Pfizer CentreOne Biological API Drug Manufacturing Product and Services
Table 130. Pfizer CentreOne Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer CentreOne Recent Developments/Updates
Table 132. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 133. Sandoz Basic Information, Manufacturing Base and Competitors
Table 134. Sandoz Major Business
Table 135. Sandoz Biological API Drug Manufacturing Product and Services
Table 136. Sandoz Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sandoz Recent Developments/Updates
Table 138. Sandoz Competitive Strengths & Weaknesses
Table 139. Vetter Basic Information, Manufacturing Base and Competitors
Table 140. Vetter Major Business
Table 141. Vetter Biological API Drug Manufacturing Product and Services
Table 142. Vetter Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Vetter Recent Developments/Updates
Table 144. Wuxi Biologics Basic Information, Manufacturing Base and Competitors
Table 145. Wuxi Biologics Major Business
Table 146. Wuxi Biologics Biological API Drug Manufacturing Product and Services
Table 147. Wuxi Biologics Biological API Drug Manufacturing Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Biological API Drug Manufacturing Upstream (Raw Materials)
Table 149. Biological API Drug Manufacturing Typical Customers
Table 150. Biological API Drug Manufacturing Typical Distributors
List of Figure
Figure 1. Biological API Drug Manufacturing Picture
Figure 2. World Biological API Drug Manufacturing Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological API Drug Manufacturing Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 5. World Biological API Drug Manufacturing Average Price (2018-2029) & (USD/MT)
Figure 6. World Biological API Drug Manufacturing Production Value Market Share by Region (2018-2029)
Figure 7. World Biological API Drug Manufacturing Production Market Share by Region (2018-2029)
Figure 8. North America Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 9. Europe Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 10. China Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 11. Japan Biological API Drug Manufacturing Production (2018-2029) & (K MT)
Figure 12. Biological API Drug Manufacturing Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 15. World Biological API Drug Manufacturing Consumption Market Share by Region (2018-2029)
Figure 16. United States Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 17. China Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 18. Europe Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 19. Japan Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 20. South Korea Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 21. ASEAN Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 22. India Biological API Drug Manufacturing Consumption (2018-2029) & (K MT)
Figure 23. Producer Shipments of Biological API Drug Manufacturing by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological API Drug Manufacturing Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological API Drug Manufacturing Markets in 2022
Figure 26. United States VS China: Biological API Drug Manufacturing Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biological API Drug Manufacturing Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological API Drug Manufacturing Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biological API Drug Manufacturing Production Market Share 2022
Figure 30. China Based Manufacturers Biological API Drug Manufacturing Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biological API Drug Manufacturing Production Market Share 2022
Figure 32. World Biological API Drug Manufacturing Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biological API Drug Manufacturing Production Value Market Share by Type in 2022
Figure 34. In-House manufacturing
Figure 35. Contract manufacturing
Figure 36. World Biological API Drug Manufacturing Production Market Share by Type (2018-2029)
Figure 37. World Biological API Drug Manufacturing Production Value Market Share by Type (2018-2029)
Figure 38. World Biological API Drug Manufacturing Average Price by Type (2018-2029) & (USD/MT)
Figure 39. World Biological API Drug Manufacturing Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Biological API Drug Manufacturing Production Value Market Share by Application in 2022
Figure 41. Monoclonal Antibody (mAb) Therapies
Figure 42. Vaccines
Figure 43. Insulin Therapies
Figure 44. Interferon Therapies
Figure 45. Other
Figure 46. World Biological API Drug Manufacturing Production Market Share by Application (2018-2029)
Figure 47. World Biological API Drug Manufacturing Production Value Market Share by Application (2018-2029)
Figure 48. World Biological API Drug Manufacturing Average Price by Application (2018-2029) & (USD/MT)
Figure 49. Biological API Drug Manufacturing Industry Chain
Figure 50. Biological API Drug Manufacturing Procurement Model
Figure 51. Biological API Drug Manufacturing Sales Model
Figure 52. Biological API Drug Manufacturing Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now